Bin Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bin Yu has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Hai-Gang Ding
Shaoxing People’s Hospital (Shaoxing Hospital of Zhejiang University), Shaoxing, China
2 shared publications - Hai-Tao Pan
Shaoxing Maternity and Child Health Care Hospital, Shaoxing, China
2 shared publications - Aiping Wang1 shared publication
Feng Zhang
Shaoxing Maternity and Child Health Care Hospital, Shaoxing, China
1 shared publication- Feng Zhang1 shared publication
Gui-Yu Xia
Shaoxing Maternity and Child Health Care Hospital, Shaoxing, China
1 shared publication
Latest Publications
- Open Access
- 17 June 2026
- Published by Polish Pharmaceutical Society in Acta Poloniae Pharmaceutica - Drug Research
- Vol. 84 (1) , 45-53
Oral Transport Characteristics and the Effects of Trigonelline With Contrast-Induced Acute Kidney Injury In Vivo and In Vitro
Background: Contrast-induced acute kidney injury (CI-AKI) and associated vascular endothelial damage represent significant clinical complications, yet effective preventive strategies remain limited. This study aims to investigate the protective efficacy of trigonelline against these injuries and elucidate its intestinal transport mechanisms to support its potential as a therapeutic agent. Methods: In this study, a contrast-induced acute kidney injury model was established in mice by tail vein injection of iohexol to investigate the kidney protective effects of trigonelline. Using a Caco-2 intestinal epithelial cell monolayer model, the transport characteristics of trigonelline and the involvement of potential transporters were systematically evaluated. Results: The concentration gradients of trigonelline used in the experiments showed no cytotoxic effects on Caco-2 cells. Trigonelline exhibited moderate intestinal absorption. The efflux transporters P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) were involved in the intestinal transport of trigonelline. Crucially, in the in vivo mouse model, trigonelline treatment significantly ameliorated iohexol-induced renal injury, evidenced by a dose-dependent reduction in serum creatinine and BUN levels, and a decrease in inflammatory cytokines (IL-6, TNF-α). Histopathological analysis confirmed that trigonelline effectively mitigated renal tubular necrosis and interstitial inflammation. Conclusion: The transport characteristics and potential vascular protective effects of trigonelline provide valuable insights for the design and development of therapeutic agents aimed at preventing contrast agent-induced vascular injury, and also contribute to a deeper understanding of the pharmacological activity of trigonelline.
- 17 June 2026
- Published by Polish Pharmaceutical Society in Acta Poloniae Pharmaceutica - Drug Research
- Vol. 84 (1) , 45-53
Open AccessOral Transport Characteristics and the Effects of Trigonelline With Contrast-Induced Acute Kidney Injury In Vivo and In Vitro
Background: Contrast-induced acute kidney injury (CI-AKI) and associated vascular endothelial damage represent significant clinical complications, yet effective preventive strategies remain limited. This study aims to investigate the protective efficacy of trigonelline against these injuries and elucidate its intestinal transport mechanisms to support its potential as a therapeutic agent. Methods: In this study, a contrast-induced acute kidney injury model was established in mice by tail vein injection of iohexol to investigate the kidney protective effects of trigonelline. Using a Caco-2 intestinal epithelial cell monolayer model, the transport characteristics of trigonelline and the involvement of potential transporters were systematically evaluated. Results: The concentration gradients of trigonelline used in the experiments showed no cytotoxic effects on Caco-2 cells. Trigonelline exhibited moderate intestinal absorption. The efflux transporters P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) were involved in the intestinal transport of trigonelline. Crucially, in the in vivo mouse model, trigonelline treatment significantly ameliorated iohexol-induced renal injury, evidenced by a dose-dependent reduction in serum creatinine and BUN levels, and a decrease in inflammatory cytokines (IL-6, TNF-α). Histopathological analysis confirmed that trigonelline effectively mitigated renal tubular necrosis and interstitial inflammation. Conclusion: The transport characteristics and potential vascular protective effects of trigonelline provide valuable insights for the design and development of therapeutic agents aimed at preventing contrast agent-induced vascular injury, and also contribute to a deeper understanding of the pharmacological activity of trigonelline.
- Open Access
SRC Knockdown Impairs Proliferation, Migration, and Invasion While Promoting Apoptosis in HTR8/SVneo Trophoblast Cells via Activation of the PI3K/Akt/Bcl-2 Signaling Pathway
SRC knockdown inhibits trophoblast cell proliferation, migration, and invasion while inducing apoptosis via activation of the PI3K/Akt/Bcl-2 signaling pathway. Trophoblast dysfunction is central to pregnancy disorders such as preeclampsia and miscarriage, yet the role of SRC, a non-receptor tyrosine kinase, in these cells remains poorly understood. This study aimed to elucidate the functional impact of SRC on trophoblast behavior and its underlying mechanism. Using siRNA-mediated knockdown in HTR8/SVneo cells, we confirmed efficient reduction of SRC mRNA and protein expression via RT-qPCR and Western blot. Functional assays demonstrated that SRC silencing significantly suppressed cell proliferation (CCK-8), migration (wound healing), and invasion (Transwell), while promoting apoptosis, evidenced by increased Annexin V-FITC/PI staining and upregulated Caspase-3 and Caspase-9 protein levels. Mechanistically, Western blot analysis revealed that SRC knockdown upregulated PI3K, Akt1, and Bcl-2 protein expression without altering IRS1 levels, indicating activation of the PI3K/Akt/Bcl-2 pro-survival pathway. This paradoxical activation appears to be a compensatory feedback insufficient to overcome SRC loss-induced dysfunction. Our findings identify SRC as a critical positive regulator of trophoblast proliferation, motility, and survival, acting through a non-canonical, IRS1-independent negative regulation of PI3K/Akt signaling. This study provides novel insights into trophoblast biology and suggests SRC as a potential therapeutic target for pregnancy complications; future in vivo studies are warranted to validate these mechanisms.
Open AccessSRC Knockdown Impairs Proliferation, Migration, and Invasion While Promoting Apoptosis in HTR8/SVneo Trophoblast Cells via Activation of the PI3K/Akt/Bcl-2 Signaling Pathway
SRC knockdown inhibits trophoblast cell proliferation, migration, and invasion while inducing apoptosis via activation of the PI3K/Akt/Bcl-2 signaling pathway. Trophoblast dysfunction is central to pregnancy disorders such as preeclampsia and miscarriage, yet the role of SRC, a non-receptor tyrosine kinase, in these cells remains poorly understood. This study aimed to elucidate the functional impact of SRC on trophoblast behavior and its underlying mechanism. Using siRNA-mediated knockdown in HTR8/SVneo cells, we confirmed efficient reduction of SRC mRNA and protein expression via RT-qPCR and Western blot. Functional assays demonstrated that SRC silencing significantly suppressed cell proliferation (CCK-8), migration (wound healing), and invasion (Transwell), while promoting apoptosis, evidenced by increased Annexin V-FITC/PI staining and upregulated Caspase-3 and Caspase-9 protein levels. Mechanistically, Western blot analysis revealed that SRC knockdown upregulated PI3K, Akt1, and Bcl-2 protein expression without altering IRS1 levels, indicating activation of the PI3K/Akt/Bcl-2 pro-survival pathway. This paradoxical activation appears to be a compensatory feedback insufficient to overcome SRC loss-induced dysfunction. Our findings identify SRC as a critical positive regulator of trophoblast proliferation, motility, and survival, acting through a non-canonical, IRS1-independent negative regulation of PI3K/Akt signaling. This study provides novel insights into trophoblast biology and suggests SRC as a potential therapeutic target for pregnancy complications; future in vivo studies are warranted to validate these mechanisms.